Hiller was the recent CEO of venture-backed cardiovascular device startup Heartscape Technologies and former Senior Vice President at Millennium Pharmaceuticals.
"The patented SciFluor technology offers companies a solution to the challenge of fluorination that has the potential to significantly accelerate and improve the drug discovery and development process," Hiller said.
Hiller brings leadership and start-up experience across pharmaceuticals, biotechnology, and medical devices, most recently raising $22 million in B-round funding and building a management and field team that placed ECG cardiovascular technology in 30 institutions nationwide.
